✦ LIBER ✦

Variable response to oral angiotensin-converting-enzyme blockade in hypertensive scleroderma patients

✍ Scribed by Hendricks H. Whitman III; David B. Case; John H. Laragh; Charles L. Christian; Gary Botstein; Hildegard Maricq; E. Carwile Leroy

Publisher: John Wiley and Sons
Year: 1982
Tongue: English
Weight: 672 KB
Volume: 25
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.1780250301

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Twelve scleroderma patients with hypertension, seven of whom had malignant hypertension and renal failure or scleroderma renal crisis, were treated with captopril. The first dose lowered mean pressure in all patients by 21.3 mmHg; in 6 patients it relieved encephalopathy. Blood pressure was controlled in all patients. Two of 7 patients with scleroderma renal crisis had improvement in renal function; the 5 patients who did not have malignant hypertension improved or stabilized. Despite good pressure control, however, renal failure developed in 5 patients with scleroderma renal crisis. The data indicated that captopril is effective antihypertensive therapy in scleroderma and, when given early, may prevent renal failure and death.

📜 SIMILAR VOLUMES

Metabolic effects of long-term angiotens

Metabolic effects of long-term angiotensin-converting enzyme inhibition with fosinopril in patients with essential hypertension: relationship to angiotensin-converting enzyme inhibition

✍ R. Reneland; P.-E. Andersson; A. Haenni; H. Lithell 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 566 KB

Fifty patients with mild to moderate essential hypertension were randomized to receive either 20 mg fosinopril daily for 16 weeks or placebo for 4 weeks followed by 12 weeks of 50 mg atenolol daily. Prior to these 16 weeks there was a placebo wash-out period of 2-6 weeks. Blood pressure measurements

Hypertensive crisis in systemic sclerosi

Hypertensive crisis in systemic sclerosis: treatment with the new oral angiotensin converting enzyme inhibitor mk 421 (enalapril) in captopril-intolerant patients

✍ C. Douglas Smith; Ronald D. Smith; Joseph H. Korn 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB

Induction of plasma carboxycathepsin (an

Induction of plasma carboxycathepsin (angiotensin I converting enzyme) of normotensive and hypertensive rats in response to A single dose of captopril

✍ E. V. Kugaevskaya; Yu. E. Eliseeva; L. V. Pavlikhina; V. N. Orekhovich; I. F. Fa 📂 Article 📅 1987 🏛 Springer US 🌐 English ⚖ 306 KB

The influence of posture on the response

The influence of posture on the response to loop diuretics in patients with chronic cardiac failure is reduced by angiotensin converting enzyme inhibition

✍ A. D. Flapan; E. Davies; C. Waugh; B. C. Williams; T. R. D. Shaw; C. R. W. Edwar 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 539 KB

The diuretic and natriuretic response to an intravenous dose of frusemide 40 mg was assessed in the erect and supine positions in 10 patients with cardiac failure who were being treated with enalapril 10 mg twice daily in addition to diuretics (Enalapril group) and in 10 patients with cardiac failur